Olaparib for Metastatic Germline BRCA-Mutated Breast Cancer
N Engl J Med
.
2017 Nov 2;377(18):1792-3.
doi: 10.1056/NEJMc1711644.
Authors
Mark Robson
1
,
Carsten Goessl
2
,
Susan Domchek
3
Affiliations
1
Memorial Sloan Kettering Cancer Center, New York, NY robsonm@mskcc.org
2
AstraZeneca, Gaithersburg, MD
3
University of Pennsylvania, Philadelphia, PA
PMID:
29091556
DOI:
10.1056/NEJMc1711644
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Phthalazines*
Piperazines*
Substances
Phthalazines
Piperazines
olaparib